<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Theralase Technologies Inc. — News on 6ix</title>
<link>https://6ix.com/company/theralase-technologies-inc</link>
<description>Latest news and press releases for Theralase Technologies Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 13 Apr 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/theralase-technologies-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f68078dffbe2df12fa41.webp</url>
<title>Theralase Technologies Inc.</title>
<link>https://6ix.com/company/theralase-technologies-inc</link>
</image>
<item>
<title>Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-reports-complete-response-with-x-ray-activated-rutherrinr-in-muscle-invasive-bladder-cancer-preclinical-study</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-reports-complete-response-with-x-ray-activated-rutherrinr-in-muscle-invasive-bladder-cancer-preclinical-study</guid>
<pubDate>Mon, 13 Apr 2026 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - Theralase&#xAE; Technologies Inc.&#xA0;(TSX...</description>
</item>
<item>
<title>Theralase(R) Closes $CAN 2.66 Million Financing</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollarcan-266-million-financing</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollarcan-266-million-financing</guid>
<pubDate>Fri, 10 Apr 2026 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Theralase&#xAE; Technologies Inc.&#xA0; (TS...</description>
</item>
<item>
<title>Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-discovers-further-mechanism-on-how-ruvidarr-inactivates-herpes-simplex-virus</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-discovers-further-mechanism-on-how-ruvidarr-inactivates-herpes-simplex-virus</guid>
<pubDate>Tue, 17 Mar 2026 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Theralase&#xAE; Technologies Inc.&#xA0;( TS...</description>
</item>
<item>
<title>Theralase(R) Closes $1.1 M Non-Brokered Private Placement</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollar11-m-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollar11-m-non-brokered-private-placement</guid>
<pubDate>Tue, 10 Mar 2026 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 10, 2026) - Theralase&#xAE; Technologies Inc. ( TSXV: T...</description>
</item>
<item>
<title>Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-demonstrates-that-x-ray-activated-rutherrinr-is-significantly-more-effective-than-radiation-alone-in-the-destruction-of-muscle-invasive-bladder-cancer</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-demonstrates-that-x-ray-activated-rutherrinr-is-significantly-more-effective-than-radiation-alone-in-the-destruction-of-muscle-invasive-bladder-cancer</guid>
<pubDate>Mon, 09 Mar 2026 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 9, 2026) - Theralase&#xAE; Technologies Inc.&#xA0; (TSX...</description>
</item>
<item>
<title>Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/light-activated-ruvidar-and-interferon-demonstrate-enhanced-efficacy</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/light-activated-ruvidar-and-interferon-demonstrate-enhanced-efficacy</guid>
<pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
<description>Theralase(R) Demonstrates Additive Anti-Cancer Effect in Bladder Cancer In-Vitro Model when Light...</description>
</item>
<item>
<title>Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/correcting-and-replacing-theralase-bladder-cancer-clinical-data-to-be-presented-at-the-2026-european-association-of-urology-congress</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/correcting-and-replacing-theralase-bladder-cancer-clinical-data-to-be-presented-at-the-2026-european-association-of-urology-congress</guid>
<pubDate>Fri, 20 Feb 2026 12:00:00 GMT</pubDate>
<description>This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position f...</description>
</item>
<item>
<title>Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralase-bladder-cancer-clinical-data-to-be-presented-at-the-2026-european-association-of-urology-congress</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralase-bladder-cancer-clinical-data-to-be-presented-at-the-2026-european-association-of-urology-congress</guid>
<pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - Theralase&#xAE; Technologies Inc. (TSXV:...</description>
</item>
<item>
<title>Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-bladder-cancer-clinical-data-to-be-presented-at-the-2026-american-urological-association-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-bladder-cancer-clinical-data-to-be-presented-at-the-2026-american-urological-association-annual-meeting</guid>
<pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that its interim clinical data has been selected for presentation at the American Urological Association ("AUA") Annual Meeting.The program..</description>
</item>
<item>
<title>Theralase(R) Provides Update on Bladder Cancer Clinical Study</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-provides-update-on-bladder-cancer-clinical-study</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-provides-update-on-bladder-cancer-clinical-study</guid>
<pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
<description>Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer...</description>
</item>
<item>
<title>Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-completes-enrollment-in-bladder-cancer-clinical-study</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-completes-enrollment-in-bladder-cancer-clinical-study</guid>
<pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Theralase&#xAE; Technologies Inc.&#xA0; (...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trade Resumption - TLT</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/canadian-investment-regulatory-organization-trade-resumption-tlt</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/canadian-investment-regulatory-organization-trade-resumption-tlt</guid>
<pubDate>Mon, 12 Jan 2026 14:32:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trade Resumption - TLT Canada NewsWire ...</description>
</item>
<item>
<title>Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/ferring-pharmaceuticals-and-theralaser-technologies-announce-clinical-development-agreement-to-investigate-combination-therapy-in-bladder-cancer</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/ferring-pharmaceuticals-and-theralaser-technologies-announce-clinical-development-agreement-to-investigate-combination-therapy-in-bladder-cancer</guid>
<pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
<description>The collaborative clinical study will evaluate ADSTILADRIN&#xAE; (nadofaragene firadenovec-vncg) ...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trading Halt - TLT</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/canadian-investment-regulatory-organization-trading-halt-tlt</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/canadian-investment-regulatory-organization-trading-halt-tlt</guid>
<pubDate>Fri, 09 Jan 2026 20:57:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trading Halt - TLT Canada NewsWire VAN...</description>
</item>
<item>
<title>Theralase(R) Closes $1.3 M Non-Brokered Private Placement</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollar13-m-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-closes-dollar13-m-non-brokered-private-placement</guid>
<pubDate>Tue, 23 Dec 2025 21:40:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase&#xAE; Technologies Inc.&#xA0; ...</description>
</item>
<item>
<title>Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-commences-non-brokered-private-placement-and-termination-of-previously-announced-financing</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-commences-non-brokered-private-placement-and-termination-of-previously-announced-financing</guid>
<pubDate>Fri, 12 Dec 2025 22:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase&#xAE; Technologies Inc.&#xA0; ...</description>
</item>
<item>
<title>Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-announces-brokered-life-financing-to-further-advance-its-phase-ii-non-muscle-invasive-bladder-cancer-clinical-study</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-announces-brokered-life-financing-to-further-advance-its-phase-ii-non-muscle-invasive-bladder-cancer-clinical-study</guid>
<pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase&#xAE; Technologies Inc. (TSXV...</description>
</item>
<item>
<title>Theralase(R) Investor Conference Call Reminder</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-investor-conference-call-reminder</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-investor-conference-call-reminder</guid>
<pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
<description>Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demo...</description>
</item>
<item>
<title>Theralase(R) Releases 3Q2025 Financial Statements</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-releases-3q2025-financial-statements</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-releases-3q2025-financial-statements</guid>
<pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase&#xAE; Technologies Inc.&#xA0;(...</description>
</item>
<item>
<title>Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug</title>
<link>https://6ix.com/company/theralase-technologies-inc/news/theralaser-demonstrates-effectiveness-of-x-ray-activated-drug</link>
<guid isPermaLink="true">https://6ix.com/company/theralase-technologies-inc/news/theralaser-demonstrates-effectiveness-of-x-ray-activated-drug</guid>
<pubDate>Mon, 03 Nov 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase &#xAE; Technologies Inc.&#xA0;...</description>
</item>
</channel>
</rss>